let's hope he has positive #$%$ to announce before that!! his market cap is getting killed and that is a failure for any CEO since their primary job is to protect and increase shareholder value.....
Shorts, congrats on the manipulation. Technicals surely broke this stock down. Plan for Ron to have new name at ASN to brand, announce early readiness for launch, with posters and discussions at ASN to saturate the nephrologists (including the few whom claim they may have not heard of Ferric Citrate yet). Drug is ready to go, efficacy detailed, economic benefit outlined, novel product to treat hyperphospatemia and anemia safely in one therapeutic.
So just to see what your beef was/is I went back and looked at my posts when MNKD was approved. Maybe you and plunger-boy have me confused with someone else. Here was what I posted... and you can verify it easily enough.
"$9+ at adcom and $11 at FDA approval... $?? is the top?
by waiting4kerx • Jun 27, 2014 8:27 PM
I'm truly and sincerely happy for the true blue longs today on approval but frankly everyone and their 2nd cousin knew about this company... heck a delivery boy this week saw my trading platform open at work and asked me if I knew anything about MannKind and I began laughing. So with 19.77% tute ownership, 29.36% of the float short, Al Mann owning a ton of shares, insiders selling, and one of the best long/short Bio drama festivals I've seen in the past few years (although OPKO is in the running) Monday as sure as he11 is hot is going to be fun to watch. My opinion is that this will go to $13 really quickly or it will take a quick hop and then painfully get stomped back down into the $8's. If it looks like a short squeeze I'm more than willing to help!!!
I think the biggest ? at this point is... will NEW RETAIL shareholders drive and keep the price up? Will the MM's (big funds and tutes) finally embrace MNKD? Lastly... and I always ask this of myself... how many longs are going to buy shares at $11+ or will they just sit around hoping for the next pay day without putting more skin into the game?
Good luck longs!
To the shorts... I hope you lose your shirt, your car, your house and even more importantly... your dignity."
NOW... was I right or wrong? It went to $13 in the premarket and was $8 a month later... now it's at $6. Don't get mad at me Bubba.
In response to the harassment that I have reported to Yahoo already. But if you want to make it even clearer to them that YOU have been harassing me----just follow me to another board------like you did before. You DO realize that YOU are the biggest idiot that I was trying to avoid responding to, don't you?
Sentiment: Strong Buy
TW, I think you must have heard him wrong.
On the Sept. 5 call, Ron said topline results "by year end 2015" and if positive expect to file SNDA "in first half of 2016."
So that's what's in my list. That is what the company is telling us.
do I now? how so? on the yahoo board I said "sell the news". on the mnkd board I always posted what I thought would happen... and it did. pumpers and dreamers don't always like reality so if that makes me a basher then so be it. frankly I hate shorts as I find them to be one of the lowest life forms on these financial m/b's. but look at my posting history... I use one ID and post on all the boards using it. nothing to hide. I don't care if you like me or not... but I'm honest and not always right. some folks would never admit that.
congratulation on your trades
you know what Chuckles... just for fun went back and checked my records and I've only lost $ on one biotech ($814) in the past few years. that was SOMX
looking at my biotech track record in just the past couple years I've made sheet loads of $ on PACB, KERX, SNTA, MNKD, ACHN, POZN, HZNP, GLYC & ACAD. and that's just the tip of the iceberg if we're going to talk about biotech.
why don't you tell us a little about yourself f face? tell us all about RMTI too while you're at it...
I normally don't post anything on the weekends, as I have better things to do, but for this, I will make an exception. I bet your points 1,3, and 4 are the exact opposite of the truth, and I believe your point no. 2 does not apply, as they are not indicated for the same market. You forget that triferic (spelled correctly) is not a phosphate binder. Ferric citrate coordination complex will become standard of care for treating hyperphosphatemia in 3 short years, and when nephrologists gather enough data on iron retention from FCCC, there will be less need (key word "less) for other iron replacement therapies. I think Triferic has a niche market carved out in ESRD on dialysis to replace IV iron and reduce ESA, but it will be more on the order of $100M in peak sales. Therefore, the market cap for RMTI has, in my opinion, already factored in the upside from Triferic. However, if FCCC gets an anemia indication (hemoglobin) in NDD-CKD, it will be a $1B blockbuster, and it is nowhere near factoring in the upside from that...
Her iron would be monitored, and unless the pill bottle was left opened on the coffee table, the grandkids that could not yet read oughta be ok. Could your argument get any weaker?
You corrected me the other day on a message. I stated that the short interest was way down, and you corrected me saying that the numbers you give are short trading numbers given everyday. I miss understood you, so I just wanted to say thanks for straightening me out. That is the good side of this message board. You can always learn something.
Thanks again and have a good weekend.
hey Pinocchio....dndn had a drug that extends life 3 mths and nobody could pay the premium. mnkd has a nich market for afrezza that will generate billions in sales.....guess you gotta be a diabetic or know a diabetic to get it. as for kerx......we're at the bottom or close to it. silly basher.JMHO
Oh thank you so much for saving us. I'm sure you have no motive and are completely unbiased. I will disregard all the price targets of all the independent analysts that range from $24 to $36 and listen solely to your incredibly intelligent insight. You are without the smartest person in the world......
oh wait a minute on second thought you're the JOKE! Now go get your 10 cents you paid mup!
Poorpicks,( now that name is accurate) the fact that you are working on football Sunday bashing Kerx gets entered into the "good sign" category. You feel the need to post bs on the sabbath in an attempt to loosen up more shares is very encouraging.
Sentiment: Strong Buy
All this talk about Kerx being oversold is a joke. Metrics make no difference in a biotech. How can something be oversold with no revenue. Remember Dndn oversold @ 40 then 30 then 20 then 10 then 2. Their drug is unique not like z.. The stock is not going down from manipulation its going down because they will not be able to market the drug effectually. All management wants is their 30 million in bonuses ,then they will move on to another biotech. It happens all the time. I feel sorry for those who bought low and are watching their profits erode because they believe the pumpers. The stock price is fragile and the chance of bad news is great, institutions selling, poor sales in Japan,no nce ect. The odds of these being negative are way more than 50 50. At $13.48 maybe the stock is over bought like Mnkd was.
1. Anemia in most CKD patients is caused by iron, vitamin B12, and folic acid deficiencies [ Ferric Citrate can treat iron deficiency]. One study has shown anemia affected 28% of people with mild kidney disease and 87% of people with severe kidney disease. Anemia tends to worsen as CKD (Chronic Kidney Disease) progresses. Most people who have total loss of kidney function, or kidney failure, have anemia.
2. 2.The tendency towards phosphate retention (which Ferric Citrate treats) increases with deterioration in renal failure. Renal failure also leads to deterioration in anemic condition. That means progression or deterioration in CKD brings both anemia and increase in phosphate levels. Hence, Ferric Citrate, which treats both of them and will be renamed soon, has a bright future.
1. In spite of slide in price after the FDA announcement, the management has not over-reacted. Company CEO, Ron issued a statement and then made a presentation, but that's all. The presentation was pretty professional without any exaggeration. I would say the management is pretty confident that they were under temporary pressure.
Traders' Psychological Recovery
1. We saw some large slides in NASDAQ stocks last week. On Keryx side there were somewhat measured moves up and down. In spite of all pressures the stock remained close to the average $13.50 line. Interestingly, during the last half an hour on Friday the up volume was more than 1 million. I think we are on an inflection point. The change in direction has already started.
I being a long found it like a Kingdaka ride. Good luck everybody, you get what you want!